Bio-Rad Laboratories, Inc. (BIO) vs Hims & Hers Health, Inc. (HIMS)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs HIMS

growth of $100 · dividends reinvested · last 7y
BIO -1.0%HIMS +190.9%HIMS compounded faster
0200400600Start $100202120232025$99$291
BIO HIMS

BIO vs HIMS: by the numbers

  • BIO is the larger company ($8.95B vs $6.54B market cap).
  • BIO is profitable (6.52% net margin) while HIMS runs a net loss (-0.56%).
  • HIMS grew revenue faster over the past five years (69.19% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOHIMS
P/E ratio52.13N/A
Forward P/E35.00N/A
P/S ratio3.292.91
P/B ratio1.2415.48
EV / EBITDA21.4878.60
FCF yield4.19%1.10%

Profitability

MetricBIOHIMS
Gross margin51.87%67.64%
Operating margin9.25%1.32%
Net margin6.52%-0.56%
ROE2.46%-2.97%
ROIC2.04%6.02%

Growth (annualized)

MetricBIOHIMS
Revenue CAGR (5Y)0.29%69.19%
EPS CAGR (5Y)-26.27%N/A
FCF CAGR (5Y)-7.57%N/A
Total return CAGR (5Y)-13.99%27.87%

Frequently asked

Which has grown faster, BIO or HIMS?
Over the past five years, HIMS grew revenue faster — BIO at a 0.29% CAGR versus HIMS at 69.19%.
Is BIO or HIMS more profitable?
BIO runs the higher net margin — BIO at 6.52% versus HIMS at -0.56%.
How have BIO and HIMS total returns compared?
Over the past 5 years, BIO delivered 8.68% and HIMS delivered 27.87% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.